Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma

European Journal of Cardio-thoracic Surgery

Volumn 34, Issue 1, 2008, Pages 204-207

  Aigner, Clemens ^a   Hoda, Mir Ali Reza ^a   Lang, Gyoergy ^a   Taghavi, Shahrokh ^a   Marta, Gabriel ^a   Klepetko, Walter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

EPP; Extrapleural pneumonectomy; Malignant pleural mesothelioma; MPM; Multi modal treatment; Pleuropneumonectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG RESECTION; MALE; MORBIDITY; MORTALITY; PATIENT SELECTION; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PLEURAL NEOPLASMS; PNEUMONECTOMY; TREATMENT OUTCOME;

EID: 45549105868     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.03.003     Document Type: Article

References (15)

1. Steele J.P., Klabatsa A., Fennell D.A., Pallaska A., Sheaff M.T., Evans M.T., Shamash J., and Rudd R.M. Prognostic factors in mesothelioma. Lung Cancer 49 Suppl. 1 (2005) S49-S52
2. de Perrot M., Uy K., Anraku M., Tsao M.S., Darling G., Waddell T.K., Pierre A.F., Bezjak A., Keshavjee S., and Johnston M.R. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 133 (2007) 111-116
3. Robinson B.W.S., Musk A.W., and Lake A.R. Malignant mesothelioma. Lancet 366 (2005) 397-408
4. Sugarbaker D.J., Heher E.C., Lee T.H., Couper G., Mentzer S., Corson J.M., Collins Jr. J.J., Shemin R., Pugatch R., and Weissman L. Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma. J Thorac Cardiovasc Surg 102 (1991) 10-14
5. Opitz I., Kestenholz P., Lardinois D., Muller M., Rousson V., Schneiter D., Stahel R., and Weder W. Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothorac Surg 29 (2006) 579-584
6. Rusch V.W. Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma. Chest 103 (1993) 382S-384S
7. Rusch V.W. A proposed new international TNM staging system for malignant pleural mesothelioma. The International Mesothelioma Interest Group. Chest 108 (1995) 1122-1128
8. Erasmus J.J., Truong M.T., Smythe W.R., Munden R.F., Marom E.M., Rice D.C., Vaporciyan A.A., Walsh G.L., Sabloff B.S., Broemeling L.D., Stevens C.W., Pisters K.M., Podoloff D.A., and Macapinlac H.A. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: staging implications. J Thorac Cardiovasc Surg 129 (2005) 1364-1370
9. Rice D.C., Erasmus J.J., Stevens C.W., Vaporciyan A.A., Wu J.S., Tsao A.S., Walsh G.L., Swisher S.G., Hofstetter W.L., Ordonez N.G., and Smythe W.R. Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surg 80 (2005) 1988-1992
10. Weder W., Stahel R., Bernhard J., Bodis S., Vogt P., Ballabeni P., Lardinois D., Betticher D., Schmid R., Stupp R., Ris H., Jermann M., Mingrone W., Roth A., and Spiliopoulos A. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 18 (2007) 1196-1202
11. Flores R.M., Krug L.M., Rosenzweig K.E., Venkatraman E., Vincent A., Heelan R., Akhurst T., and Rusch V.W. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol 1 (2006) 289-295
12. Rea F., Marulli G., Bortolotti L., Breda C., Favaretto A.G., Loreggian L., and Sartori F. Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): feasibility and results. Lung Cancer 57 (2007) 89-95
13. Martin-Ucar A.E., Nakas A., Edwards J.G., and Waller D.A. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma. Eur J Cardiothorac Surg 31 (2007) 765-770
14. Vogelzang N.J., Rusthoven J.J., Symanowski J., Denham C., Kaukel E., Ruffie P., Gatzemeier U., Boyer M., Emri S., Manegold C., Niyikiza C., and Paoletti P. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 (2003) 2636-2644
15. van Meerbeeck JP, Gaafar R, Manegold C, Van Klaveren RJ, Van Marck EA, Vincent M, Legrand C, Bottomley A, Debruyne C, Giaccone G, European Organisation for Research and Treatment of Cancer Lung Cancer Group; National Cancer Institute of Canada. J Clin Oncol 2005;23:6881-6889.